
Sarah Ketterer's 13F: The 17.6% AstraZeneca Consolidation
Sarah Ketterer’s Causeway 13F Portfolio: Deep Value Turnarounds & Massive AZN Signal 👉 Want this level of research on superinvestors and public companies... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm
Show notes












